These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1107511
21. [Validation of sterile pharmaceutical production. Considerations and experiences]. Pongiluppi S. Boll Chim Farm; 1985 Jul; 124(7):293-305. PubMed ID: 4074520 [No Abstract] [Full Text] [Related]
22. [Practical applications of L.A.L. in the pharmaceutical industry (author's transl)]. Fussellier M. J Pharm Belg; 1979 Jul; 34(3):137-41. PubMed ID: 480118 [No Abstract] [Full Text] [Related]
23. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures]. Anastasio P, Carazzone M, Genova R, Malesani L, Molinari ML. Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577 [No Abstract] [Full Text] [Related]
24. Pharmaceutical GMPs. Bobrowicz G. Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629 [No Abstract] [Full Text] [Related]
25. The biotest RCS air samplers in unidirectional flow. Ljungqvist B, Reinmüller B. J Pharm Sci Technol; 1994 Jun; 48(1):41-4. PubMed ID: 8004418 [Abstract] [Full Text] [Related]
26. Validation and routine operation of a sterile dry powder filling facility. Prout G. J Parenter Sci Technol; 1982 Jun; 36(5):199-204. PubMed ID: 6927748 [No Abstract] [Full Text] [Related]
27. BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry. Danner K. Dev Biol Stand; 1993 Jun; 80():199-205. PubMed ID: 8270110 [Abstract] [Full Text] [Related]
28. Contamination control in contract filling of small volume parenterals. Sherman NE. Bull Parenter Drug Assoc; 1970 Jun; 24(3):148-52. PubMed ID: 5422903 [No Abstract] [Full Text] [Related]
30. [Contamination control. 1. The sterile working bench]. Wahlström L. Sven Farm Tidskr; 1966 Nov 10; 70(31):729-33. PubMed ID: 5979053 [No Abstract] [Full Text] [Related]
31. Control of the aseptic processing environment. Frieben WR. Am J Hosp Pharm; 1983 Nov 10; 40(11):1928-35. PubMed ID: 6650522 [Abstract] [Full Text] [Related]
32. Microbiological control in the manufacture of sterile pharmaceutical products. Bühlmann X. Pharm Acta Helv; 1971 Jul 10; 46(7):385-409. PubMed ID: 4934853 [No Abstract] [Full Text] [Related]
33. A method for evaluating the effectiveness of preservative systems in water-immiscible ointments. Abshire RL, Schlech BA. J Parenter Sci Technol; 1982 Jul 10; 36(5):216-21. PubMed ID: 6765553 [No Abstract] [Full Text] [Related]
34. Control aspects of aseptically produced products. Avallone HL. J Parenter Sci Technol; 1985 Jul 10; 39(2):75-9. PubMed ID: 3989616 [No Abstract] [Full Text] [Related]
35. Anticipated revisions to the current good manufacturing practice regulations. Mitchell CM. Bull Parenter Drug Assoc; 1974 Jul 10; 28(3):146-51. PubMed ID: 4845938 [No Abstract] [Full Text] [Related]
36. [Importance of methods used for microbiologic control of topical drugs]. Plaza CJ, de la Rosa MC, García Arribas ML, Mosso MA. Pharm Acta Helv; 1987 Jul 10; 62(2):48-52. PubMed ID: 3554267 [No Abstract] [Full Text] [Related]
37. GMP and quality trends in Europe. Sharp J. J Parenter Sci Technol; 1990 Jul 10; 44(6):296-9. PubMed ID: 2277315 [No Abstract] [Full Text] [Related]
38. Laminar flow in the pharmaceutical industry. Hortig HP. Bull Parenter Drug Assoc; 1973 Jul 10; 27(1):38-47. PubMed ID: 4686287 [No Abstract] [Full Text] [Related]
39. Proper use of biological indicators in sterilization. Brewer JH, Phillips GB. Bull Parenter Drug Assoc; 1968 Jul 10; 22(4):157-69. PubMed ID: 4914499 [No Abstract] [Full Text] [Related]
40. Biological indicators in the pharmaceutical and the medical device industry. Pflug IJ, Odlaug TE. J Parenter Sci Technol; 1986 Jul 10; 40(5):242-8. PubMed ID: 3540254 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]